On 15th June 2015, Cancer52 responded to the proposed changes to the Standard Operating Procedures: Cancer Drugs Fund 2015-16. In...

We are delighted to announce that our new report “Rare and Less Common Cancers: Incidence and Mortality in England, 2010 to 2013” is...

Following our successful Parliamentary event in December, details of how the last government answered our questions on rare and less...

On 23rd April 2015, Cancer52 responded to the NHS public consultation on Investing in Specialised Services. In summary Cancer52 believes...

On 23 April, Cancer52 responded to the NHS public consultation on Investing in Specialised Services. Read more of our submission.

We are pleased to share the presentations delivered at the quarterly All Members Meeting on 21st April 2015 at Wellington House: Nicky...

We are pleased to share the presentations delivered at the quarterly All Members Meeting on 21st April 2015 at Wellington House: Dr...

Cancer52 is delighted to announce that Jonathan Pearce, chief executive of the Lymphoma Association, has been appointed as Chair of...

We are pleased to share with members the presentations given at the Cancer52 Patient Engagement Event at Friends House: Daniel Ratchford...

Some 15 Cancer52 members attended the Cancer Strategy workshop. The attendees spent two hours providing feedback in three areas:...